0001127602-12-011832.txt : 20120326 0001127602-12-011832.hdr.sgml : 20120326 20120326164517 ACCESSION NUMBER: 0001127602-12-011832 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120322 FILED AS OF DATE: 20120326 DATE AS OF CHANGE: 20120326 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Haluska Frank CENTRAL INDEX KEY: 0001494892 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21696 FILM NUMBER: 12714905 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS, INC. STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0305 4 2012-03-22 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001494892 Haluska Frank C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 SVP, Clinical R&D, CMO Common Stock 2012-03-22 4 M 0 13333 0 A 52198 D Common Stock 2012-03-23 4 S 0 6667 15.4069 D 45531 D Restricted Stock Units 0 2012-03-22 4 M 0 13333 0 D 2020-03-22 Common Stock 13333 13333 D Shares were acquired upon vesting of restricted stock units awarded on March 22, 2010. Represents shares sold to satisfy withholding tax requirements related to the vesting of restricted stock units. Shares were sold pursuant to a Rule10b5-1 trading plan adopted by the reporting person on December 22, 2011. Each restricted stock unit represents a right to receive one share of ARIAD common stock. The restricted stock units vested on March 22, 2010. /s/Edward M. Fitzgerald, Attorney-in-Fact 2012-03-26